Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vancomycin for Surgical Site Infection Prophylaxis in Ankle Fractures
NCT05363462Completed
- Sponsor
- Universidad Autónoma de Nuevo León
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in surgical site infection (SSI) comparing Topical Vancomycin with Standard of Care (2 arms). Primary endpoint: Rate of surgical infection site at 90 days. Started Jan 2022; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05363462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05363462.